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Antinociceptive, antiinflammatory, and antioxidant activities
of the ethanol extract of Crataegus orientalis leaves*
Zeynep BOR1, Rana ARSLAN1, Nurcan BEKTAŞ1, Sevda PIRILDAR2, Ali Aslan DÖNMEZ3
Aim: To determine the in vitro antioxidant activity and to investigate the possible antinociceptive and antiinflammatory
effects of the ethanol extract of Crataegus orientalis leaves. The medicinal use of extracts prepared from the leaves,
flowers, and fruits of Crataegus (hawthorn) dates back to ancient times. It has been proposed that its antioxidant
constituents account for these beneficial therapeutic effects.
Materials and methods: To evaluate these effects, the hot-plate, tail-immersion, writhing, and carrageenan-induced
edema tests were used. Moreover, the antioxidant activity of the extract was determined using the 2,2-diphenyl-1picrylhydrazyl and β-carotene-linoleic acid assay systems. In the tests that were used to determine antinociceptive and
antiinflammatory effects, the extract was administered in dose ranges of 50, 100, and 200 mg/kg, intraperitoneally.
Results: In the hot-plate test, the doses of 100 and 200 mg/kg exerted significant antinociceptive effects. In the tailimmersion test, antinociceptive effects were significant in all of the doses. In the writhing test, as the dose increased, a
significant decrease in the writhing responses was observed. The antiinflammatory test results showed a dose-dependent
antiinflammatory activity. In vivo tests also showed the extract as possessing antioxidant activity.
Conclusion: According to the experimental findings, the ethanol extract of C. orientalis displays remarkable
antinociceptive, antiinflammatory, and antioxidant activities.
Key words: Crataegus orientalis, hawthorn, antinociception, antiinflammation, antioxidant

Crataegus orientalis yapraklarının etanol ekstresinin antinosiseptif,
anti-inflamatuvar ve antioksidan etkileri
Amaç: Crataegus (alıç) bitkisinin türlerinin yaprak, çiçek ve meyvelerinden hazırlanan ekstrelerinin ilaç olarak
kullanımı çok eski zamanlara dayanmaktadır. Alıcın yararlı terapötik etkilerinin antioksidan içeriğinden kaynaklandığı
ileri sürülmektedir. Bu çalışmada Crataegus orientalis yapraklarının etanol ekstresinin in vitro antioksidan aktivitesinin
belirlenmesi ve olası antinosiseptif, ve antiinflamatuvar etkilerinin araştırılması amaçlanmıştır.
Yöntem ve gereç: Ekstrenin bu etkilerinin değerlendirilmesi için hot-plate, tail-immersion, kıvranma ve karragenin ile
indüklenen pençe ödem testleri kullanılmıştır. Ekstrenin antioksidan aktivitesi 2,2-difenil-1-pikrilhidrazil ve β-karotenlinoleik asit sistemi kullanılarak tayin edilmiştir. Antinosiseptif ve antiinflamatuvar etkilerin belirlenmesi için uygulanan
testlerde ekstrenin 50, 100 ve 200 mg/kg olarak hazırlanan dozları intraperitoneal olarak verilmiştir.
Bulgular: Hot-plate testinde 100 ve 200 mg/kg dozlarında antinosiseptif etkide anlamlılık gözlenmiştir. Tail-immersion
testinde tüm dozlarda görülen antinosiseptif etki kontrole göre anlamlılık göstermiştir. Kıvranma testinde ise doz
arttıkça kıvranma sayılarında önemli bir düşüş görülmüştür. Antiinflamatuvar etki testinden elde edilen sonuçlar doza
bağımlı bir etkinlik göstermiştir. Yapılan in vivo testlerde ekstrenin antioksidan aktiviteye sahip olduğu görülmüştür.
Sonuç: Deneylerden elde edilen bulgulara göre, C. orientalis etanol ekstresinin antinosiseptif, antiinflamatuvar ve
antioksidan aktivitelerinin dikkate değer olduğu sonucuna varılmıştır.
Anahtar sözcükler: Crataegus orientalis, alıç, antinosiseptif, anti-inflamatuvar, antioksidan
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Introduction

Material and methods

Hawthorn (Crataegus spp.), belonging to the family
Rosaceae, grows in northern temperate regions such
as East Asia, Europe, and eastern North America (1).
The extracts or tinctures prepared from the leaves,
flowers, and/or fruits of Crataegus have been used
traditionally since ancient times (2,3). The plant
is mainly used for the treatment of cardiovascular
diseases. In addition, according to pharmacological
studies, extracts of Crataegus may also be used
as antiinflammatory and antioxidant agents (4).
Flavonoids and oligomeric proanthocyanidins
(OPCs), the main constituents of hawthorn, are
responsible for most of the pharmacological
activity (1). The flowers contain the highest levels of
flavonoids and the leaves contain the highest levels
of OPC. It has been reported that the plants that
contain these components show antinociceptive
and antiinflammatory activities (4). Although some
hawthorn species such as Crataegus monogyna
and Crataegus pinnatifida have been studied for
their antiinflammatory and antioxidant activities
(5,6), there are no scientific studies about the
antinociceptive and antiinflammatory activities of
Crataegus orientalis.

Drugs and chemicals

It has been reported that the genus Crataegus
consists of nearly 21 species in Turkey (7). C.
orientalis, which is called Anatolian hawthorn and
is also locally known as “geyikdikeni” in Turkey, is
native to the Mediterranean region, Turkey, Crimea,
and western Iran. C. orientalis prefers man-made
habitats, clearing areas in the steppe, and other open
places. The species has many local types and extreme
forms. Its fruits are commonly used as food (8,9).
The flavonoid content of C. orientalis leaves was
investigated and the main component was found
to be hyperoside, along with apigenin, apigenin-7glucoside, vitexin, and vitexin-4’-rhamnoside (10).
As C. orientalis may have antinociceptive and
antiinflammatory actions since it is rich in flavonoids,
the aim of the present study was to provide scientific
evidence for the analgesic and antiinflammatory
activities of the ethanol extract of C. orientalis leaves
using appropriate models in mice. In addition, the
antioxidant capacity of Crataegus orientalis ethanol
extract (COE) was also evaluated and the total
phenolic content was determined.
316

The following drugs and chemicals were obtained
from the following sources in this study: methanol,
dimethyl sulfoxide (DMSO), acetic acid, and Tween
80 from Merck (Darmstadt, Germany); and morphine
sulfate, diclofenac, naloxone, Folin-Ciocalteu reagent,
β-carotene, gallic acid, butylated hydroxytoluene
(BHT), 2,2-diphenyl-1-picrylhydrazyl (DPPH),
carrageenan, chloroform, sodium carbonate, TrisHCl buffer, and linoleic acid from Sigma (St. Louis,
MO, USA).
Plant material
C. orientalis M.Bieb. var. szovitsii (Pojark.) leaves
were collected from Gaziantep in Turkey on 27
May 2002. The plant material was identified by
Prof Dr Ali A. Dönmez from the Department of
Biology of the Faculty of Science at Hacettepe
University. An authenticated voucher specimen
(A.A.Dönmez10693) was deposited in the herbarium
of the Faculty of Biology of Hacettepe University.
Preparation of the ethanol extract of C. orientalis
leaves
The leaves of the plant material were air-dried at room
temperature under shade and then powdered. The
plant material was extracted in 50% ethanol using a
Soxhlet apparatus for 18 h. The ethanol extract was
lyophilized, resulting in the crude dry extract (11.82
g, 23.15% yield).
Phytochemical screening
The COE was tested for the presence of alkaloids,
tannins, reducing sugar, and phenolics using standard
phytochemical screening procedures. In each test, a
10% (w/v) methanol solution of the extract was used
(11). The total phenolic content of the extract was
determined using the Folin-Ciocalteu method. The
total phenolic contents were estimated as gallic acid
equivalents, expressed as milligrams of gallic acid per
gram of extract (12,13). In a 10.0-mL volumetric flask,
6.0 mL of H2O and 100 μL of sample were transferred,
and 500 μL of undiluted Folin-Ciocalteu reagent was
subsequently added to the mixture. After 1 min, 1.5
mL of a solution containing 20% (w/v) Na2CO3 was
added, and the volume was increased to 10.0 mL with
H2O. After 2 h of incubation at 25 °C, the absorbance
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was measured at 760 nm and compared to a gallic
acid calibration curve. The data are presented as the
averages of triplicate analyses.
Pharmacological procedures
Animals

hot plate was set to 55 ± 0.5 °C and the mice were put
on the plate for testing (n = 6-8). The reaction time
of the pain response (hind paw licking, hind paw
flicking, or jumping) at 30 min after drug injection
was measured. The cut-off time for the hot-plate test
was 20 s (15).

Swiss albino mice (30-40 g) were obtained from the
Anadolu University Experimental Animal Research
Center. The animals were maintained in a room
with controlled temperature (22 ± 2 °C) for a light/
dark photoperiod of 12:12, with free access to food
and water. Before each experiment, in order to
avoid a possible interaction with food, the animals
received only water for 12 h. Animal care and
research protocols were based on the principles and
guidelines adopted in the Guide for the Care and Use
of Laboratory Animals (NIH Publication No: 8523, revised in 1985) and were approved by the local
ethics committee of Anadolu University, Eskişehir.

To evaluate the central mechanism of analgesic
activity, the tail immersion method was used, as
described by Schmauss and Yaksh (16). Pain reactions
were produced by thermal stimuli, by dipping the tip
of the animal’s tail into a water bath heated to 52.5 ±
0.2 °C (Heto-Holten, Allerod, Denmark) (n = 6-7).
The withdrawal time of the tail from the hot water (in
seconds) was noted as the reaction time, and it was
measured at 30 min after treatment. The maximum
cut-off time for the tail-immersion test was 15 s to
avoid injury to the tissues of the tail.

Drugs and administration

Writhing test

All of the drugs, injected intraperitoneally (IP)
30 min before the procedure, were dissolved in a
20% solution of DMSO in saline (v/v). COE was
given to the animals at doses of 50, 100, and 200
mg/kg. The same volume (0.1 mL) of the vehicle
was administrated to the negative control group.
Morphine sulfate (5 mg/kg) and diclofenac (10
mg/kg) were used as the reference analgesic drugs.
In order to evaluate possible involvement of the
opioid system in the antinociceptive effect of the
COE, the mice were pretreated 10 min before the
administration of the extracts (50, 100, and 200 mg/
kg) with the nonselective opioid receptor antagonist
naloxone (5 mg/kg).

This method is a chemical visceral pain model
used to assess the peripheral antinociceptive
activity, described by Koster et al. (17). The mice
were injected IP with 10 mL/kg of 0.6% acetic acid
solution to develop visceral pain after 30 min of the
administration of the drugs or extracts (n = 6-7). The
intensity of the nociceptive behavior was quantified
by counting the total number of writhes for 10 min,
5 min after the administration of the acetic acid. The
writhing response consists of a contraction of the
abdominal muscles together with a stretching of the
hind limbs.

Acute toxicity
The mice were divided into the control and test groups
(n = 6). COE was administered IP to different groups
at increasing doses of 50, 100, 200, 400, 800, and 1000
mg/kg. The mice were allowed food and water ad
libitum during the acute toxicity study and all of the
animals were observed for possible mortality cases
and behavioral changes for 72 h (14).
Hot-plate test
Pain reflexes in response to a thermal stimulus were
measured using Hot Plate Analgesia Meter No. 7280
from Ugo Basile Instruments (Comerio, Italy). The

Tail-immersion test

Carrageenan-induced hind paw edema
The carrageenan-induced hind paw edema model
was used for determination of antiinflammatory
activity (18,19). Each mouse was injected with 40 μL
(1%) carrageenan by intraplantar administration in
the right hind paw 35 min after the IP injection of the
test sample. As the control, 40 μL of saline solution
was injected into the left hind paw (n = 7-8). The
thicknesses of the injected paws were measured every
90 min during the 6-h period after the induction
of inflammation using a digital caliper. The mean
values of the treated groups were compared with the
mean values of the control group and analyzed using
statistical methods. Diclofenac (10 mg/kg) was used
as the reference drug.
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Antioxidant activity
DPPH free radical-scavenging activity
The ability of the extracts to scavenge DPPH radicals
was determined using the method of Gyamfi et
al. (20). A 50-μL aliquot of the extract in 50 mM
Tris-HCl buffer (pH 7.4) was mixed with 450 μL
of Tris-HCl buffer and 1.0 mL of 0.1 mM DPPH in
methanol. After 30 min of incubation in darkness
at ambient temperature, the resultant absorbance
(A) was recorded at 517 nm. The percent of DPPH
decolorization of the sample was calculated
according to this equation: decolorization% = [1 –
(Asample/Acontrol)] × 100. BHT and gallic acid were used
as positive controls. The values are presented as the
means of triplicate analyses.
β-Carotene bleaching assay
In a flask, 1 mL of β-carotene (0.2 mg/mL, dissolved
in chloroform) was added to a mixture of linoleic
acid (40 mg) and Tween 80 (400 mg). Chloroform
was evaporated under a stream of nitrogen and
50 mL of distilled water was added and shaken
vigorously. The control was prepared without the
sample or standards with the same procedure. Blanks
of the control and sample were also prepared without
β-carotene. Their absorbance values were measured
on a spectrophotometer at 470 nm. The samples
were then subjected to thermal autoxidation by
keeping them in a constant-temperature water bath
at 50 °C for 2 h. The rate of bleaching of β-carotene
was monitored by taking the absorbance at 15-min
intervals (21). BHT served as the positive control. The
assay was repeated 3 times. The antioxidant activity
level (AA) of the extract was evaluated as β-carotene
bleaching using the following equation:
AA% = 100 × [1 – ( As0 – As120 )/( Ac0 – Ac120 )],
where As0 and Ac0 are the absorbance values measured
at time 0 of the incubation for the test sample and
control, respectively, and As120 and Ac120 are the
absorbance values measured in the test sample and
control, respectively, after incubation for 120 min.
Analyses of data and statistics
The statistical analyses were carried out using
GraphPad Prism Version 5.0. Data obtained from
the antioxidant assays were presented as mean values
± standard deviation (SD). Data obtained from the
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animal experiments were expressed as mean values ±
standard error of the mean (SEM) to show variation
among the groups. Statistical differences between the
treatments and the control were evaluated by one-way
ANOVA, followed by Tukey’s multiple comparison
tests. The results were expressed as the differences
and were considered significant when P ≤ 0.05.
The results of the tail-immersion and hot-plate
tests were given as a percentage of the maximal
possible effect (MPE) ± SEM, which was calculated
as follows:
MPE% = [(postdrug latency) – (predrug latency)/
(cutoff time) – (predrug latency)] × 100.
The percentage of analgesic activity of the writhing
test was defined using the following equation:
Percentage analgesic activity = [(N – N1)/N] ×
100,
where N is the average number of writhes of the
control group and N1 is the average number of
writhes of the test group).
Results
Phytochemical screening
Phytochemical investigations of the COE showed
the presence of phenolics, tannins, and alkaloids.
The amount of total phenolics in the extract was
determined by the Folin-Ciocalteu method. The total
phenolic content, expressed as gallic acid equivalents,
was 98.24 ± 2.4 mg/g in the COE.
Acute toxicity
Administration of COE at doses of 50-1000 mg/kg
did not produce mortality during the observation
period of 72 h. During observation of the animals,
those administered 400, 800, and 1000 mg/kg of the
extract exhibited decreased mobility for almost 10 h,
but no sign of convulsions. This result indicates that
COE has a low toxicity profile.
Hot-plate test
In the hot-plate test (Figure 1), MPE% values were
observed as 3.55 ± 0.69% (control), 30.02 ± 1.79%
(morphine), 6.71 ± 0.61% (COE, 50 mg/kg), 9.72 ±
1.25% (COE, 100 mg/kg), and 14.62 ± 1.07% (COE,
200 mg/kg), respectively. When compared with the
control value, 100 mg/kg and 200 mg/kg of COE
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The inhibitory effects of COE and morphine on the
tail-immersion test in mice are shown in Figure 2.
The MPE% values were calculated as 1.33 ± 0.15%
(control), 27.40 ± 1.73% (morphine, 5 mg/kg), 12.55
± 0.90% (COE, 50 mg/kg), 16.36 ± 1,50% (COE,
100 mg/kg), and 23.04 ± 1.73% (COE, 200 mg/kg),
respectively. Based on these results, the doses of 50,
100, and 200 mg/kg increased the MPE% value for
nociception significantly above the control value (P
< 0.001). There were no significant differences in
the antinociceptive effects of 50, 100, and 200 mg/
kg of COE when compared with morphine, but the
antinociceptive effect of 200 mg/kg was slightly lower
than that of morphine. The antinociceptive activity
of all of the drugs used in this test was antagonized
by naloxone. However, naloxone only significantly
decreased the antinociceptive effect produced by
morphine (P < 0.001) and the doses of 100 and 200
mg/kg of COE (P < 0.001).

The results of the acetic acid-induced writhing
responses in mice that indicate the analgesic activity
of COE are presented in Figure 3. It was found that
all of the doses of the extract caused a significant
inhibition of the writhing responses induced by

LX

Tail-immersion test

Writhing test

N

showed antinociceptive activity (P < 0.001). Naloxone
influenced the antinociceptive activity of the COE at
the doses of 100 mg/kg (P < 0.05) and 200 mg/kg (P
< 0.001).

Figure 2. Antinociceptive effects of the COE from leaves,
morphine, and the reversal effect of naloxone (NLX)
in the tail-immersion test. Values are presented as
the mean ± SEM (n = 6-7). aaaP < 0.001, significant
difference from control; bbbP < 0.001, significant
difference from morphine alone; ddP < 0.01, significant
difference from COE at 100 mg/kg alone; and eeeP <
0.001, significant difference from COE at 200 mg/kg
alone.

Number of w rithes

Figure 1. Antinociceptive effects of the COE from leaves,
morphine, and the reversal effect of naloxone (NLX)
in the hot-plate test. Values are presented as the mean
± SEM (n = 6-8). aaaP < 0.001, significant difference
from control; bbbP < 0.001, significant difference from
morphine alone; ddP < 0.01, significant difference from
COE at 100 mg/kg alone; and eeeP < 0.001, significant
difference from COE at 200 mg/kg alone.
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Figure 3. Antinociceptive effects of the COE from leaves,
morphine, diclofenac (DF), and the reversal effect of
naloxone (NLX) in the acetic acid-induced writhing
test. Values are presented as the mean ± SEM (n = 6-7).
aaa
P < 0.001, significant difference from the control; bP
< 0.05, significant difference from DF; bbbP < 0.001,
significant difference from DF; and cccP < 0.001,
significant difference from morphine alone.
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acetic acid when compared to the control (P < 0.001),
with percentage inhibitions of 100% (morphine),
63.56% (diclofenac), 66.66% (COE at 50 mg/kg),
83.72% (COE at 100 mg/kg), and 96.67% (COE at
200 mg/kg). An increase in the doses of the plant
extract resulted in a greater inhibition of writhing.
The COE doses of 100 and 200 mg/kg of the extract
were statistically more effective than the reference
drug diclofenac (P < 0.05 and P < 0.001, respectively).
The antinociceptive effect of COE was antagonized
by pretreatment with naloxone. The reversal effect of
naloxone on the antinociceptive effect of COE (50,
100, and 200 mg/kg) was lower than its effect on
morphine and there was no significant antagonism.
Carrageenan-induced hind paw edema
As shown in Table 1, the COE significantly inhibited
carrageenan-induced paw edema in mice and
exhibited a dose-dependent antiinflammatory
activity. The inhibitory values of edema at 270 min
after the carrageenan were 45.2%, 86.6%, and 96.8%
for the 50, 100, and 200 mg/kg doses of the extract,
respectively. The 200 mg/kg dose of the extract was
significant at 180 and 270 min when compared with
diclofenac (10 mg/kg).

activity. In order to compare the DPPH scavenger
capacity of the extract, known antioxidative
substances such as BHT and gallic acid were used.
The antioxidant activity of the reference substances
was evaluated at only a concentration of 0.1 mg/mL
because the substances possess maximum inhibition
at minimum concentrations. The DPPH radicalscavenging activities of the extract at 4 different
concentrations and the reference substances are
shown in Table 2 as inhibition percentage values. The
maximum inhibition percentage value of the extract
was 62.91 ± 3.40% at the concentration of 10 mg/mL.
β-Carotene bleaching assay
The antioxidant potential of COE was evaluated by
determining the ability of 1 mg/mL of extract to
inhibit β-carotene oxidation. The antioxidant activity
of the plant extract was compared with that of BHT.
The antioxidant activity of the extract, as well as of
the positive control and BHT, as measured by the
bleaching of β-carotene, is presented in Figure 4.
The rate of β-carotene bleaching (oxidation) was
reduced by 42.37%, whereas BHT inhibited the rate
of oxidation by 92.08%.

DPPH radical-scavenging activity

Discussion

By using a stable DPPH free radical, the leaves of
C. orientalis were tested for free radical-scavenging

C. orientalis has wide natural distribution and
consumption in Turkey, but the biological potency

Table 1.

The effects of C. orientalis ethanol extract against carrageenan-induced paw edema in mice (values in parentheses indicate
inhibition percentage).
Swelling thickness (×10–2 mm) ± SEM (inhibition %)

Test samples

Dose (mg/kg)
90 min

180 min

270 min

360 min

34.85 ± 0.07

52.42 ± 0.05

62.57 ± 0.07

44.57 ± 0.09

50

33.57 ± 0.06

37.8 5 ± 0.04
a
(27.78)

34.28 ± 0.03
aaa
(45.20)

31.71 ± 0.05

100

25.25 ± 0.03

16.37± 0,02
aaa, b
(68.76)

83.75 ± 0.01
aaa
(86.61)

38.75 ± 0.01
aaa
(91.30)

200

11.14 ± 0.02
a
(68.02)

9.71 ± 0.02
aaa, bb
(81.46)

2.00 ± 0.01
aaa, bb
(96.80)

2.85 ± 0.01
aaa
(93.58)

10

31.28 ± 0,05

29.85 ± 0.03
aaa
(43.04)

22.57 ± 0.03
aaa
(63.92)

11.71 ± 0.03
aaa
(73.71)

Control
COE

Diclofenac
a

P < 0.05, significant from the control value. bP < 0.05, significant from the diclofenac value.
P < 0.001, significant from the control value. bbP < 0.01, significant from the diclofenac value.

aaa
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Table 2. Scavenging activity of DPPH radicals of C. orientalis ethanol extract at 4 different concentrations.
Inhibition % ± SD
Test samples
0.1 mg/mL
COE
Gallic acid

1 mg/mL

3 mg/mL

5 mg/mL

10 mg/mL

51.37 ± 4.47

54.12 ± 6.60

62.09 ± 3.50

62.91 ± 3.40

_

_

_

_

90.00 ± 2.21

Antioxidant activity %

100
90
80
70
60
50
40
30
20
10
0
Methanol

COE

BHT

Figure 4. Antioxidant activities (%) of the C. orientalis ethanol
extract by the β-carotene bleaching method. Each
value is expressed as mean ± SD (n = 3).

of C. orientalis has not been investigated sufficiently,
especially in animal models. Hence, some of the
pharmacological effects of the extract were evaluated
here. The present study demonstrates that the COE
from leaves has antinociceptive, antiinflammatory,
and antioxidant activities and shows no lethal toxicity
at up to a dose of 1 g/kg in mice.
For the evaluation of the central antinociceptive
effects of COE, hot-plate and tail-immersion tests
were used to evaluate central pain at the supraspinal
and spinal levels, respectively (22). It is known that
the opioidergic system and descending inhibition
pathways, which involve the noradrenergic and
serotonergic systems, play an important role in the
regulation/modulation of pain at the spinal and
supraspinal levels (23,24).
The COE exerted significant antinociceptive
effects in the tail-immersion test in comparison to
the hot-plate test, which indicated that the extract
has more potent analgesic activities at the spinal level
than the supraspinal level. The obtained experimental
findings suggest that the pain systems mentioned
above may have a role in the antinociceptive activities
of the COE. In both tests, the antinociceptive effects
of the extract (100 and 200 mg/kg) were partially
inhibited by the opioid antagonist naloxone. Thus, it

is possible that the opioid mechanisms may mediate
the antinociceptive effects of COE. It is known that
the analgesic effects of opioid agents are due to the
inhibition of supraspinal receptors μ1, κ3, δ1, and σ2
and spinal receptors μ2, κ1, and δ2 (25,26). In light
of this information, it was thought that COE may
have higher affinity to spinal receptors μ2, κ1, and
δ2. However, since the antinociceptive effects were
partially inhibited by naloxone, involvement of the
noradrenergic and serotonergic pathways should
also be considered. In addition, intraperitoneal
administration of COE produced a dose-related
antinociception. It seems quite possible that the
higher doses of the extract may have more potent
central antinociceptive effects.
The writhing test is a typical model that has
been used as a screening tool for the assessment
of both peripherally and centrally acting analgesic
or antiinflammatory properties of new agents.
Induction of writhing by acetic acid causes the
release of endogenous substances such as bradykinin,
substance P, histamine, serotonin, and prostaglandins,
which excite the pain nerve endings. These nerve
endings are sensitive to analgesics such as narcotics
and nonsteroidal antiinflammatory drugs (NSAIDs)
(27-29). The writhing test results indicated that COE
significantly reduced the number of writhes. The
obtained responses were similar to that of morphine
at the COE dose of 200 mg/kg; moreover, at the doses
of 100 and 200 mg/kg, the activity of the extract
was more potent than that of diclofenac (10 mg/
kg). However, unlike morphine, the analgesia of the
extract in the acetic acid-induced writhing test was
partially naloxone-reversible, suggesting a different
mechanism of action, which may include a possible
inhibition of cyclooxygenase enzymes.
The carrageenan-induced hind paw edema is
a commonly used in vivo model for prediction of
antiinflammatory drug activity (30). Subcutaneous
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injection of carrageenan into the paw in order
to develop edema is a biphasic event. Release
of proinflammatory agents such as histamine
and serotonin is attributed to the initial phase,
which can cause the sensitization of the central
nociceptive neurons. The following phase of edema
is due to the release of prostaglandins, protease,
and lysosome, which are sensitive to most clinically
effective antiinflammatory drugs (31,32). The COE
administration resulted in a marked inhibition
of important events related to the inflammatory
response induced by carrageenan. The COE, at the
dose of 200 mg/kg, showed an antiinflammatory
effect after 90 min. All of the doses of COE possessed
an antiinflammatory effect at 3 h, and the edema
produced at this peak is thought to be due to the
release of kinin-like substances, especially bradykinin
(33,34). This finding also supports the antinociceptive
activities that were seen in the writhing test.
The first step in investigating the antioxidant
potential of the COE involved defining its ability
to scavenge free radicals to inhibit the oxidative
process. According to the antioxidant activity results,
COE was shown to possess a moderate inhibition
of free radicals (51.37%-62.91%) in DPPH radicalscavenging activity. However, the scavenging effects
of BHT and gallic acid were much more effective at
an extremely low concentration.
The absence of an antioxidant results in the
rapid discoloration of β-carotene in the β-carotene
bleaching assay. This discoloration occurs as a
consequence of free radical formation by the coupling
of β-carotene and linoleic acid (35). Although the
antioxidant activity of COE was lower than that of
synthetic BHT (92.08%), it showed almost 50%
activity. Therefore, it is thought that the extract was
effective at inhibiting lipid peroxidation.
Flavonoids and OPCs are the main constituents
responsible for the biological activity of Crataegus
species. The phytochemical analysis showed that
C. orientalis leaves contain flavonoids, mainly

hyperoside (quercetin-3-O-galactoside) and OPCs
(4,10). Rylski et al. reported that hyperoside and
OPC exerted analgesic action in the hot-plate test
(36). In addition, various studies have suggested that
plant materials that contain tannins, alkaloids, OPCs,
flavonoids, and phenolic acids have antinociceptive
and antiinflammatory effects in experimental animals
(4,37,38). Since the extract is known to contain
flavonoids and has antioxidant activity, it is possible to
speculate that these compounds might be responsible
for the antinociceptive and antiinflammatory effects
of C. orientalis leaves.
In conclusion, the present study reports, for the
first time, the antinociceptive and antiinflammatory
activities of the ethanol extract of C. orientalis leaves.
Since some of the current opioids and NSAIDs have
side effects and low potency, they may not be useful in
all cases. Thus, the potent antiinflammatory effect and
remarkable antinociceptive effect of the C. orientalis
extract may provide support in the treatment of
painful and inflammatory diseases. Moreover, the
extract has a low toxicity profile, which indicates
therapeutic safety for the pharmacologically active
doses. The mechanisms of these activities need to be
further studied with different antagonists, such as
adrenergic or serotonergic. In future investigations,
the different fractions of C. orientalis should be
evaluated and the structural characterization of
responsible components should be clarified.
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